Seed investment firm Hummingbird VC, which previously invested in Deliveroo, Peak Games, MarkaVIP, and Kraken has a new Managing Partner. Firat Ileri, previously...

PARIS & DIJON, France–(BUSINESS WIRE)–Regulatory News: Oncodesign (ALONC – FR0011766229), a biopharmaceutical group specializing in precision medicine, announced today the strengthening of its...

HOUSTON–(BUSINESS WIRE)–$KRBP #KRBP–Kiromic BioPharma, Inc. (Nasdaq: KRBP) (the “Company”), an immuno-oncology target discovery and gene-editing company with a proprietary artificial intelligence neural network...

Step Will Advance Precision Oncology By Enabling Greater Efficiency in Clinical Decision Making CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Oncology practices will now...

The latest launch from DEUS Finance now enables traders to connect to the DEUS platform via Heco, with access to over 500 stocks. Heco users can trade on DEUS with lightning-fast transaction speeds and incredibly low fees. DEUS Finance is a secure, transparent, and KYC-free platform. Below is a selection of stocks currently worth looking […]

The medical device remains a crucial component in improving the quality of life. Key players in the medical technology arena are going on...

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$NBTX #NBTXNews–Regulatory News: NANOBIOTIX (Paris:NANO) (NASDAQ:NBTX) (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology...

Data to be Presented at the 2021 Annual Meeting of the American Society for Clinical Oncology Results show NBTXR3 plus radiotherapy could...

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$NBTX #NBTXNews–Regulatory News: NANOBIOTIX (Euronext : NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering...

There’s a lot of how-to guidance out there when it comes to starting a company, and much of it has reinforced certain beliefs,...

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$NBTX #NBTX–Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering...

Pureos Bioventures has hit a $205m final close for its debut fund, which will look to back developers of novel biological drugs and...